Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,651,822
  • Shares Outstanding, K 16,009
  • Annual Sales, $ 1,783 M
  • Annual Income, $ 205,540 K
  • 60-Month Beta 1.09
  • Price/Sales 4.23
  • Price/Cash Flow 31.86
  • Price/Book 11.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 4.13
  • Number of Estimates 2
  • High Estimate 4.17
  • Low Estimate 4.09
  • Prior Year 3.35
  • Growth Rate Est. (year over year) +23.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
433.34 +11.50%
on 01/03/20
486.16 -0.61%
on 01/29/20
+44.47 (+10.14%)
since 12/27/19
3-Month
393.59 +22.76%
on 10/31/19
486.16 -0.61%
on 01/29/20
+71.02 (+17.23%)
since 10/29/19
52-Week
292.11 +65.41%
on 01/30/19
486.16 -0.61%
on 01/29/20
+190.87 (+65.30%)
since 01/29/19

Most Recent Stories

More News
Zacks.com featured highlights include: Gibraltar Industries, Amedisys, Chevron, MDU Resources and Chemed

Zacks.com featured highlights include: Gibraltar Industries, Amedisys, Chevron, MDU Resources and Chemed

MDU : 29.63 (-0.13%)
AMED : 183.35 (+1.06%)
CHE : 482.60 (+0.97%)
CVX : 110.56 (-0.50%)
ROCK : 56.45 (+0.48%)
Shares of CHE Up 15.8% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Chemed Corp (NYSE:CHE) on November 19th, 2019 at $418.18. In approximately 2 months, Chemed Corp has returned 15.78% as of today's recent price of $484.16.

CHE : 482.60 (+0.97%)
Buy These 5 Low Leverage Stocks This Earnings Season

With the Q4 reporting cycle gaining pace slowly, investors should look for stocks that are less debt-ridden compared to others instead of considering earnings growth only.

MDU : 29.63 (-0.13%)
AMED : 183.35 (+1.06%)
CHE : 482.60 (+0.97%)
CVX : 110.56 (-0.50%)
ROCK : 56.45 (+0.48%)
Chemed To Report Fourth-Quarter 2019 Earnings February 18, Related Conference Call To Be Held On February 19

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2019, on Tuesday, February 18, 2020, following the close of trading on the...

CHE : 482.60 (+0.97%)
Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ICLR : 173.52 (+0.33%)
CHE : 482.60 (+0.97%)
CRL : 158.70 (+1.13%)
PINC : 35.14 (-0.57%)
Invest in These 5 Low Leverage Stocks Before Q4 Earnings

Companies displaying high earnings growth along with high leverage ratios should be avoided while making investment decisions. So, investors should select companies with low leverage.

MDU : 29.63 (-0.13%)
OMCL : 84.87 (+0.46%)
CHE : 482.60 (+0.97%)
AMED : 183.35 (+1.06%)
OMP : 15.35 (-2.60%)
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes "

Chemed (CHE) could produce exceptional returns because of its solid growth attributes.

CHE : 482.60 (+0.97%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 83.38 (+0.58%)
CHE : 482.60 (+0.97%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 83.38 (+0.58%)
CHE : 482.60 (+0.97%)
Why Is Chemed (CHE) Up 7.7% Since Last Earnings Report?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CHE : 482.60 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CHE with:

Business Summary

Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest...

See More

Key Turning Points

2nd Resistance Point 488.21
1st Resistance Point 483.09
Last Price 482.60
1st Support Level 475.25
2nd Support Level 472.53

See More

52-Week High 486.16
Last Price 482.60
Fibonacci 61.8% 412.03
Fibonacci 50% 389.14
Fibonacci 38.2% 366.24
52-Week Low 292.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar